NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01650805,Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC),https://clinicaltrials.gov/study/NCT01650805,,TERMINATED,The purpose of this study is to compare the efficacy of ponatinib and imatinib in patients with newly diagnosed chronic myeloid leukemia (CML) in the chronic phase.,YES,Chronic Myeloid Leukemia,DRUG: ponatinib|DRUG: imatinib (Gleevec/ Glivec),"Major Molecular Response (MMR) Rate at 12 Months, A ratio of reverse transcribed transcript of BCR-ABL to ABL â‰¤ 0.1% on the international scale, measured by real-time quantitative polymerase chain reaction., 12 months after first dose","MMR Rate, To compare the efficacy of ponatinib with imatinib, as measured by MMR rate, at 5 years, 5 years after first dose|<10% BCR-ABL^IS Rate, To compare the proportion of patients achieving a ratio of \<10% BCR-ABL to ABL transcript levels at 3 months, as measured by the international scale (\<10% BCR-ABL\^IS), in patients administered ponatinib versus those administered imatinib, 3 months after first dose|Complete Cytogenetic Response (CCyR) Rate, The percentage of Ph+ metaphases in bone marrow (peripheral blood may not be used), with a review of a minimum of 20 metaphases. Responses are defined as follows: Complete (CCyR): 0% Ph+ metaphases., 12 months after first dose|Progression-free Survival, To compare, according to treatment with ponatinib versus imatinib, progression-free survival, Up to 8 years after the last patient's first dose|Overall Survival, To compare, according to treatment with ponatinib versus imatinib, overall survival, Up to 8 years after the last patient's first dose",,Ariad Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,307,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,AP24534-12-301,2012-06,2013-10,2013-10,2012-07-26,2014-10-21,2014-11-17,"US Oncology - Providence Health System, Site #167, Burbank, California, 91505, United States|UCLA Department of Medicine, Site #027, Los Angeles, California, 90095, United States|Bay Area Cancer Research Group, Site #156, Pleasant Hill, California, 94523, United States|Bay Area Cancer Research Group, Site #157, Pleasant Hill, California, 94523, United States|Rocky Mountain Cancer Centers, Site #191, Boulder, Colorado, 80303, United States|Cancer Center of Central Connecticut, Site #147, Southington, Connecticut, 06489, United States|Christiana Care Health Services, Site #155, Newark, Delaware, 19713, United States|University Cancer Institute, Site #149, Boynton Beach, Florida, 33426, United States|Florida Cancer Specialists, Site #180, Fort Meyers, Florida, 33916, United States|Florida Cancer Specialists, Site #179, St. Petersburg, Florida, 33705, United States|Emory University, Site #058, Atlanta, Georgia, 30322, United States|John H. Stroger, Jr. Hospital of Cook County, Site #192, Chicago, Illinois, 60612, United States|University of Chicago, Site #001, Chicago, Illinois, 60637, United States|Loyola University Chicago, Site #054, Maywood, Illinois, 60153, United States|Franciscan St. Francis Health, Site #138, Indianapolis, Indiana, 46237, United States|University of Iowa Hospitals and Clinics, Site #050, Iowa City, Iowa, 52242, United States|Siouxland Hematology-Oncology Associates, Site #198, Sioux City, Iowa, 51101, United States|US Oncology - Cancer Center of Kansas, Site #168, Wichita, Kansas, 67214, United States|Willis-Knighton Cancer Center, Site #196, Shreveport, Louisiana, 71103, United States|University of Maryland, Greenebaum Cancer Center, Site #040, Baltimore, Maryland, 21201, United States|Greater Baltimore Medical Center, Site #140, Baltimore, Maryland, 21204, United States|St. Agnes Healthcare, Site #185, Baltimore, Maryland, 21229, United States|Massachusetts General Hospital, Site #047, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Site #008, Boston, Massachusetts, 02215, United States|University of Massachusetts Worcester, Site #152, Worcester, Massachusetts, 01655, United States|University of Michigan Medical Center, Site #011, Ann Arbor, Michigan, 48109, United States|Providence Cancer Institute, Site #197, Southfield, Michigan, 48075, United States|Mayo Clinic, Site #044, Rochester, Minnesota, 55905, United States|Oncology Research Park Nicollet Institute, Site #195, St. Louis Park, Minnesota, 55426, United States|Saint Luke's Hospital, Site #162, Kansas City, Missouri, 64111, United States|Mercy Clinic - Cancer & Hematology, Site #151, Springfield, Missouri, 65804, United States|Nebraska Hematology-Oncology, P.C., Site # 133, Lincoln, Nebraska, 68506, United States|US Oncology - Comprehensive Cancer Center of Nevada, Site #169, Las Vegas, Nevada, 89169, United States|John Theurer Cancer Center, Site #128, Hackensack, New Jersey, 07601, United States|University of New Mexico Cancer Center, Site #166, Albuquerque, New Mexico, 87106, United States|Maimonides Cancer Center, Site #177, Brooklyn, New York, 11220, United States|Winthrop University Hospital, Site #153, Mineola, New York, 11501, United States|Beth Israel Medical Center, Site #145, New York, New York, 10003, United States|Mount Sinai School of Medicine, Site #189, New York, New York, 10029, United States|Memorial Sloan-Kettering Cancer Center, Site #078, New York, New York, 10065, United States|Weill Cornell Medical College, Site #006, New York, New York, 10065, United States|New York Medical College, Site #146, Valhalla, New York, 10595, United States|Southeastern Medical Oncology Center, Site #188, Goldsboro, North Carolina, 27534, United States|Signal Point Clinical Research Center, Site #139, Middletown, Ohio, 45042, United States|University of Oklahoma, Site #028, Oklahoma City, Oklahoma, 73104, United States|Providence Cancer Center Oncology and Hematology Care Eastside, Site #194, Portland, Oregon, 97213, United States|Kaiser Permanente Northwest, Site #200, Portland, Oregon, 97227, United States|Oregon Health & Science University, Site #048, Portland, Oregon, 97239, United States|Gettysburg Cancer Center, Site #160, Gettysburg, Pennsylvania, 17325, United States|Western Pennsylvania Hospital, Site #159, Pittsburgh, Pennsylvania, 15224, United States|Medical University of South Carolina, Site #148, Charleston, South Carolina, 29425, United States|Carolina Hematology Oncology, Site #143, Sumter, South Carolina, 29150, United States|Associates in Oncology & Hematology, Site #186, Chattanooga, Tennessee, 37421, United States|Sarah Cannon Research Institute, Site #076, Nashville, Tennessee, 37203, United States|US Oncology - Texas Oncology Austin, Site #172, Austin, Texas, 78705, United States|US Oncology - Texas Oncology Dallas, Site #171, Dallas, Texas, 75231, United States|University of Texas Southwestern Medical Center, Site #178, Dallas, Texas, 75390, United States|Baylor College of Medicine, Site #063, Houston, Texas, 77030, United States|US Oncology - Texas Oncology Midland, Site #173, Midland, Texas, 79701, United States|US Oncology - Cancer Care Center of South Texas, Site #170, San Antonio, Texas, 78229, United States|Huntsman Cancer Institute, Site #043, Salt Lake City, Utah, 84112, United States|VCU Massey Cancer Center, Dalton Oncology Clinic, Site #069, Richmond, Virginia, 23298, United States|Seattle Cancer Care Alliance, Site #100, Seattle, Washington, 98109, United States|US Oncology - Northwest Cancer Specialists, Site #174, Vancouver, Washington, 98684, United States|West Virginia University, Site #154, Morgantown, West Virginia, 26506, United States|Green Bay Oncology, Ltd. / St. Mary's Hospital Medical Center, Site #193, Green Bay, Wisconsin, 54303, United States|University of Wisconsin, Site #030, Madison, Wisconsin, 53792, United States|Canberra Hospital, Site #971, Garran, Australian Capital Territory, 2605, Australia|Royal North Shore Hospital, Site #941, Sydney, New South Wales, 2065, Australia|Royal Adelaide Hospital, Site #951, Adelaide, South Australia, 5000, Australia|The Peter MacCallum Cancer Center, Site #950, East Melbourne, Victoria, 3002, Australia|Box Hill Hospital, Site #940, Melbourne, Victoria, 3128, Australia|Royal Perth Hospital, Site #972, Perth, Western Australia, 6000, Australia|Medizinische Universitat Wien / AKH, Universitatsklinik fur Inniere Medizin I, Site #561, Wien, 01090, Austria|UZ Brussel - Department Hematology, Site #544, Brussel, Belgium|Clinique Universitaire de Saint-Luc, Department of Haematology, Site #508, Bruxelles, 3000, Belgium|UZ Gent - Department Hematology, Site #756, Gent, Belgium|UZ Gasthuisberg - Department of Hematology, Site #700, Leuven, 3000, Belgium|University Health Network, Princess Margaret Hospital, Site #083, Toronto, Ontario, M5G 2M9, Canada|Jewish General Hospital, Site #129, Montreal, Quebec, H3T 1E2, Canada|Fakultni nemocnice Brno, Interni hematologicka a onkologicka klinika, Site #514, Brno, 62500, Czech Republic|FN Hradec Kralove, Site #517, Hradec Kralove, 50005, Czech Republic|Fakultni nemocnice Olomouc, Hematoonkologicka klinika, Site #515, Olomouc, 77520, Czech Republic|Ustav hematologie a krevni transfuse, Site #516, Praha, 12808, Czech Republic|Helsinki University Central Hospital, Site #542, Helsinki, Finland|Institut Bergonie, Site #772, Bordeaux, France|CHRU de Brest, Hopital Morvan, Site #523, Brest, 29200, France|CHU Henri Mondor, Site #520, Creteil Cedex, 94010, France|Centre Hospitalier de Versailles, Site #958, Le Chesnay Cedex, France|Hospital Claude Huriez, Site #952, Lille Cedex, 59037, France|Institut Paoli Calmette, Site #519, Marseille, France|CHU de Brabois, Site #953, Nancy Cedex, France|CHU de Nantes, Site #521, Nantes Cedex, 44093, France|Service Hematologie - Hospital Archet I, Site #509, Nice Cedex, 06202, France|Hopital Saint-Louis, Site #957, Paris, 75475, France|Hospital Saint Antoine, Site #518, Paris, France|Centre Hospitalier Lyon Sud, Site #956, Pierre Benite, 69495, France|CHU de Poitiers, Site #954, Poitiers, 86021, France|CHU Purpan, Site #955, Toulouse Cedex, France|UniversitÃ¤tsklinikum Aachen, AÃ–R, Site #513, Aachen, 52074, Germany|Charite - Universitatsmedizin Berlin, Site #701, Berlin, 13353, Germany|Universitatsklinikum Carl Gustav Carus an der TU Dresden, Site #526, Dresden, 01307, Germany|Universitatsklinikum Freiburg, Site #527, Freiburg, Germany|Universitatsklinikum Hamburg-Eppendorf, Site #524, Hamburg, 20246, Germany|Universitatsklinikum Jena, Site #946, Jena, 07747, Germany|Universitatsklinikum Koln-AOR, Site #525, Koln, 50937, Germany|Universitat Heidelberg, CML - Studienzentrale III. Medizinische Klinik, Site #947, Mannheim, 68167, Germany|Klinikum rechts der Isar, Site #949, Munchen, 81675, Germany|Prince of Wales Hospital, Site #974, Hong Kong, Hong Kong|Queen Mary Hospital, Site #973, Hong Kong, Hong Kong|Unita Operativa di Ematologia con Trapianto, Site #529, Bari, 70124, Italy|Istituto di Ematologia ""L. & A. Seragnoli"", Site #959, Bologna, 40138, Italy|A.O. Universitaria Policlinico Vittorio Emanuele di Catania, Site #530, Catania, 95124, Italy|Clinica Ematologica, Site #528, Genova, 16132, Italy|Ospedale Niguarda Ca' Granda di Milano, Site #531, Milan, 20162, Italy|S.C. Ematologia, Site #960, Modena, 41124, Italy|San Gerardo Hospital, Site #961, Monza, 20900, Italy|U.O.C Ematologia con trapianto di midollo osseo, Site #560, Napoli, 80131, Italy|Universita Federico II, Site #510, Napoli, Italy|SCDU Medicina Interna II - Indirizzo Ematologico, Site #785, Orbassano, 10043, Italy|Dipartimento di Biotecnologie Cellulari ed Ematologia Universita La Sapienza - Policlinico Umberto I, Site #511, Rome, 00161, Italy|U.O. di Ematologia - Ospedale S. Eugenio, Site #962, Rome, 144, Italy|The Catholic University of Korea, Site #938, Seocho-gu, Seoul, 137-701, Korea, Republic of|VU Medical Centre - Department Haematology, Site #948, Amsterdam, 1081-HV, Netherlands|Auckland City Hospital, Site #921, Grafton, Auckland, 1023, New Zealand|Christchurch Hospital, Site #922, Christchurch, New Zealand|Waikato Hospital, Site #977, Hamilton, New Zealand|North Shore Hospital, Site #976, Takapuna, 0740, New Zealand|Klinika Hematologii i Transplantologii, Uniwersyteckie Centrum Medyczne, Site #548, Gdansk, Poland|Malopolskie Centrum Medyczne, Site #546, Krakow, Poland|Klinika Hematologii Wojewodzkiego Szpitala Specjalistycznego, Site #550, Lodz, Poland|Oddzial Hematologii, Site #551, Rzeszow, 35-055, Poland|Katedra i Klinika Hematologii, Site #547, Wroclaw, Poland|Instituto Portugues de Oncologia, Site #545, Lisboa, 1099-023, Portugal|Fundacion de Investigacion de Diego, Site #199, San Juan, 00927, Puerto Rico|Singapore General Hospital, Site #939, Singapore, Singapore|Narodny onkologicky ustav, Site #532, Bratislava, 833 10, Slovakia|Univerzitna nemocnica Martin, Site #533, Martin, 036 59, Slovakia|Complejo Hospitalario Universitario A Coruna, Hospital ""Teresa Herrera,"" Site #554, A Coruna, 15006, Spain|Hospital Universitari Germans Trias i Pujol, Site #512, Badalona, 08916, Spain|Hospital Clinic, Site #963, Barcelona, 08036, Spain|Institut Catala d' Oncologia de Girona, S. de Hematologia Clinica, Site #734, Girona, 17007, Spain|Hospital Universitari Son Espases, Site #553, Islas Baleares, 07010, Spain|Hospital Universitario La Princesa, Site #555, Madrid, 28006, Spain|Hospital Gregorio Maranon, Site #536, Madrid, 28007, Spain|H.U. Ramon y Cajal, Site #538, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Site #537, Madrid, 28041, Spain|Hospital La Paz, Site #966, Madrid, 28046, Spain|Hospital Universitario Central de Asturias, Site #535, Oviedo, 33006, Spain|Hospital Universitario de Salamanca, Site #965, Salamanca, 37007, Spain|Hospital Clinico Universitario de Valencia, Site #964, Valencia, 46010, Spain|Skane University Hospital, Site #944, Lund, Sweden|Karolinska University Hospital Huddinge, Site #534, Stockholm, Sweden|Karolinska University Hospital Solna, Site #763, Stockholm, Sweden|Uppsala University Hospital, Site #945, Uppsala, Sweden|Kantonsspital Aarau, Site #541, Aarau, 5001, Switzerland|Kantonsspital St. Gallen, Site #707, St Gallen, 9007, Switzerland|Kaohsiung Chang Gung Memorial Hospital, Site #980, Kaohsiung, Taiwan|China Medical University Hospital, Site #978, Taiching, 40447, Taiwan|National Taiwan University Hospital, Site #979, Taipei, 10002, Taiwan|Western General Hospital, Site #556, Edinburgh, EH4 2XU, United Kingdom|Kent and Medway Cancer Research Network, Site #558, Gillingham, United Kingdom|University of Glasgow, Site #797, Glasgow, G120SB, United Kingdom|St. James University Hospital, Site #540, Leeds, LS9 7TF, United Kingdom|Royal Liverpool University Hospital, Site #969, Liverpool, L7 8XP, United Kingdom|Hammersmith Hospital, Site #967, London, United Kingdom|Newcastle University, Site #970, Newcastle, United Kingdom|Norfolk & Norwich University Hospital Foundation Trust, Site #557, Norwich, United Kingdom|Nottingham University Hospitals NHS Trust, Site #968, Nottingham, NG5 1PB, United Kingdom|Oxford University Hospitals NHS Trust, Site #543, Oxford, United Kingdom",
